Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol
-
Juliana Salazar
Abstract
Background: The cellular retinoic acid-binding protein II (CRABP-II), together with nuclear receptors such as the retinoid X receptor (RXR) and retinoic acid receptor (RAR), is involved in the transcriptional regulation of genes that control lipid metabolism via the retinoid signaling pathway and, as such, may be associated with disorders of lipid metabolism. Interestingly, the gene for CRABP-II is located on chromosome 1q21–23, which is a region that has been linked with disorders such as familial combined hyperlipidemia (FCHL), type 2 diabetes mellitus, and partial lipodystrophy, all of which are characterized by dyslipidemia.
Methods: We investigated the hypothesis that the CRABP2 gene is involved in the regulation of lipid metabolism. Using the promoter –394T>C polymorphism of the CRABP2 gene, we performed association studies in three different cohorts: 299 healthy males, 182 HIV-infected patients and 151 patients with familial hypercholesterolemia (FH). All cholesterol measurements were performed in the absence of any lipid-lowering agents. ANOVA was performed on data adjusted for age, body mass index (BMI), gender, and use of protease inhibitors.
Results: The frequency of the C allele was 0.03 in the three groups. Among healthy males, carriers of the C allele had 9% higher total plasma cholesterol (p=0.027) and 13% higher low-density lipoprotein cholesterol (LDL-C) concentrations (p=0.020). In HIV-infected patients, multivariate analysis of four measures over a 1-year period showed that carriers of the C allele had significantly higher LDL-C of between 10% and 31% (p=0.001) compared with non-carriers of the allele. FH patients who were carriers of the C allele had 16% higher LDL-C (p=0.038). The C allele was significantly over-represented among hypercholesterolemic patients (p=0.001).
Conclusions: Our results show that the CRABP2 gene, a member of the retinoid signaling pathway, is associated with increased plasma LDL-C concentrations.
Clin Chem Lab Med 2007;45:615–20.
©2007 by Walter de Gruyter Berlin New York
Articles in the same Issue
- 6th Conference on Homocysteine Metabolism, World Congress on Hyperhomocysteinemia, Saarbruecken/Germany June 5-9, 2007
- The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes
- Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
- Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study
- Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels
- Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions
- HLA-DQA1 and -DQB1 allele typing in southern Taiwanese women with breast cancer
- Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol
- Frequency of two human glutathione-S-transferase omega-1 polymorphisms (E155 deletion and E208K) in Ovambo and Japanese populations using the PCR-based genotyping method
- Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case
- Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients
- Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
- Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome
- A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry
- Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats
- Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
- Measurement of calcitonin by immunoassay analyzers
- Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X
- Quality indicators and specifications for key processes in clinical laboratories: a preliminary experience
- Analytical and clinical performance of three natriuretic peptide tests in the emergency room
- Quality of serum creatinine measurement in light of EQA programs
- Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias
- Comparison between AlaTOP and IP8 inhalant panels on the Immulite 2000 analyzer
- External quality assessment of urinary methylmalonic acid quantification – results of a pilot study
Articles in the same Issue
- 6th Conference on Homocysteine Metabolism, World Congress on Hyperhomocysteinemia, Saarbruecken/Germany June 5-9, 2007
- The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes
- Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
- Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study
- Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels
- Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions
- HLA-DQA1 and -DQB1 allele typing in southern Taiwanese women with breast cancer
- Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol
- Frequency of two human glutathione-S-transferase omega-1 polymorphisms (E155 deletion and E208K) in Ovambo and Japanese populations using the PCR-based genotyping method
- Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case
- Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients
- Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
- Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome
- A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry
- Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats
- Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
- Measurement of calcitonin by immunoassay analyzers
- Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X
- Quality indicators and specifications for key processes in clinical laboratories: a preliminary experience
- Analytical and clinical performance of three natriuretic peptide tests in the emergency room
- Quality of serum creatinine measurement in light of EQA programs
- Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias
- Comparison between AlaTOP and IP8 inhalant panels on the Immulite 2000 analyzer
- External quality assessment of urinary methylmalonic acid quantification – results of a pilot study
